日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ASK1/ p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancer

ASK1/p38轴抑制可阻断肝细胞线粒体“危险信号”的释放,并抑制肝硬化和肝癌的进展。

Peng, Zhenwei; Wei, Guangyan; Huang, Pinzhu; Matta, Heansika; Gao, Wen; An, Ping; Zhao, Shuangshuang; Lin, Yi; Tan, Li; Vaid, Kahini; Skelton-Badlani, Disha; Nasser, Imad; Budas, Grant; Lopez, David; Li, Li; Breckenridge, David; Myers, Rob; McHutchison, John; Kuang, Ming; Popov, Yury V

Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science

从药物研发和监管科学的角度重新定义脂肪肝疾病,从非酒精性脂肪性肝病 (NAFLD) 到代谢性脂肪性肝病 (MAFLD)

Fouad, Yasser; Palmer, Melissa; Chen, Minjun; Regev, Arie; Banerjee, Rajarshi; Myers, Rob; Riccio, Robert; Torstenson, Richard; Younes, Ramy; Arora, Puneet S; Landgren, Henrik; Karsdal, Morten A; Blake, Martin; Shapiro, David A; Gruss, Hans-Juergen; Sheikh, Muhammad Y; Attia, Dina; Bollipo, Steven; Smith, Alastair D; Freilich, Bradley; Gish, Robert G; Schuppan, Detlef

Longitudinal analysis of serum microRNAs as predictors of cirrhosis regression during treatment of hepatitis B virus infection.

纵向分析血清微小RNA作为乙型肝炎病毒感染治疗期间肝硬化消退的预测指标

Orr Cody, Myers Rob, Li Biao, Jiang Zhaoshi, Flaherty John, Gaggar Anuj, Meissner Eric G

The Second Canadian Symposium on hepatitis C virus: a call to action

第二届加拿大丙型肝炎病毒研讨会:行动呼吁

Grebely, Jason; Bilodeau, Marc; Feld, Jordan J; Bruneau, Julie; Fischer, Benedikt; Raven, Jennifer F; Roberts, Eve; Choucha, Norma; Myers, Rob P; Sagan, Selena M; Wilson, Joyce A; Bialystok, Frank; Tyrrell, D Lorne; Houghton, Michael; Krajden, Mel